Entelai
Entelai builds AI diagnostic agents for medical imaging (mammography, brain MRI, X-ray) and clinical workflow automation, serving hospitals, diagnostic centers, and patients across Latin America via subscription licensing and a WhatsApp consumer channel.
- Company typePrivate
- Founded2019
- HeadquartersBuenos Aires, Argentina
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Entelai does
Entelai is a Buenos Aires-based healthtech company that develops AI-powered diagnostic agents for medical imaging and clinical workflow automation, primarily serving healthcare institutions and medical specialists across Latin America. Its product portfolio includes Agent Mammo (mammography triage with reported sensitivity above 95%), Agent Neuro (quantitative brain MRI volumetry against age-adjusted normative databases), Agent X-Ray (chest and extremity radiograph interpretation), and Agent Flex (clinical and administrative process automation for institutions and pharmaceutical companies). These are unified in Agent One, a multimodal diagnostic platform launching in April 2026 that integrates imaging analysis with natural-language pre-report generation and RIS/PACS interoperability. The technology stack rests on convolutional neural networks trained on millions of imaging studies, GPU-accelerated inference, and computer vision pipelines, with NLP applied to report drafting and patient interaction.
The company monetizes through annual subscription licensing of its AI agents to hospitals, diagnostic centers, and radiology practices, with quote-based pricing tied to deployment scope and modalities. A secondary consumer motion, Entelai Doc, delivers prescriptions, medical orders, and preventive checkups directly to patients via WhatsApp on a freemium model, with a free preventive checkup tier (DocCheck) launching in April 2026. Go-to-market is hybrid: enterprise field sales targeting high-complexity hospitals and pharmaceutical companies, paired with self-serve WhatsApp distribution for individual consumers. Named enterprise customers include FLENI and Hospital de Clínicas in Buenos Aires, and the company markets across Argentina, Brazil, Colombia, Mexico, and Peru, with INVIMA regulatory clearance supporting Colombian operations. The company is privately held, co-founded by CEO Mauricio Farez (Harvard-trained neurologist, 100+ publications) and Diego Fernández Slezak (PhD in Computer Science, NLP/medical imaging researcher).
Entelai firmographics
Firmographics- Name
- Entelai
- Legal name
- Entelai
- Website
- https://entelai.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Entelai builds AI diagnostic agents for medical imaging (mammography, brain MRI, X-ray) and clinical workflow automation, serving hospitals, diagnostic centers, and patients across Latin America via subscription licensing and a WhatsApp consumer channel.
- Ownership category
- akta.pro rank
Where Entelai is headquartered
LocationHeadquarters
- HQ city
- Buenos Aires
- HQ country
- Argentina
- HQ region
- Latin America
Offices1 record
Markets served
Entelai business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- AI Diagnostic Agents (Agent Mammo, Neuro, X-Ray): Subscription-based licensing of AI diagnostic agents for medical imaging analysis. Offered to hospitals, diagnostic centers, and radiology practices with clinical validation and implementation support.
- Agent Flex - Enterprise Automation: Customizable AI automation platform for institutions, from administrative tasks to regulatory documentation and clinical data analysis. Scaled pricing based on institution size and automation scope.
- Agent One - Multimodal Diagnostic Platform: Upcoming (April 2026) unified diagnostic platform combining all modalities. Enterprise licensing model with integration into existing RIS/PACS systems.
- Entelai Doc - Patient Services: Patient-facing digital health services including prescription requests, medical orders, and health checkups via WhatsApp. Free preventive checkups with optional paid medical documentation orders.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise AI agents for institutions |
| Freemium | Pay-as-you-go | Entelai Doc consumer services |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Entelai product offering
Product offeringCore offering
Entelai develops AI-powered diagnostic agents that analyze medical images (mammograms, brain MRIs, chest X-rays, and other modalities) to assist radiologists and healthcare institutions in faster, more accurate diagnosis. Its flagship consumer product, Entelai Doc, lets individuals obtain AI-assisted health assessments via WhatsApp, while its enterprise suite (Agent Mammo, Agent Neuro, Agent X-Ray, Agent Flex, Agent One) integrates into hospital RIS/PACS workflows across Latin America.
Differentiator
Problem solved
Functional benefit
Brands
- Agent One: Unified multimodal diagnostic platform integrating multiple imaging modalities (mammography, neuro, X-ray, flex) for automated pre-report generation with natural language interaction. Launch expected April 2026.
- Agent Mammo
- Agent Neuro
- Agent X-Ray
- Agent Flex
- Entelai Doc
- DocCheck
Products and services
- Agent Mammo AI diagnostic agent that analyzes mammography images to assist radiologists and breast imaging centers in screening and detection. Used by hospitals and imaging centers as part of the Entelai enterprise suite.
- Agent Neuro AI diagnostic agent that interprets brain MRI studies to support neurology and radiology teams in identifying findings faster and more consistently. Targeted at hospitals and imaging centers running MRI services.
- Agent X-Ray AI diagnostic agent that analyzes chest X-ray images to assist radiology and emergency care teams in triaging and interpreting studies. Used by hospitals, clinics, and diagnostic imaging centers.
- Agent Flex Configurable AI agent offering that lets healthcare institutions extend Entelai's diagnostic AI capabilities beyond the standard mammography, neuro, and X-ray agents to additional modalities or workflows.
- Agent One Unified enterprise AI platform that combines Entelai's diagnostic imaging agents into one integrated offering for healthcare institutions seeking a single contract and deployment.
- Entelai Doc Consumer-facing AI health assistant delivered via WhatsApp that lets individuals submit medical images and lab results for AI-assisted interpretation, including a free first check and the DocCheck paid report feature. Targeted at patients and the general public.
Quantifiable outcome
- Mammography workload reduced by up to 60% with triage mode
- +6 more outcomes
Companies that use Entelai
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Entelai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability10 records
Feature6 records
Entelai partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- INVIMAminorINVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) certification appears on Entelai's website, indicating regulatory approval for operations in Colombia and Latin American market access.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Entelai competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Customer concentration
Entelai social profiles
Digital presenceEntelai financial estimates
Financial estimateRevenue estimate
Valuation estimate
Entelai leadership team
Management profileNumber of profiles
Profiles2 records
Entelai funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Entelai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Entelai
What does Entelai do?
Entelai develops AI-powered diagnostic agents that analyze medical images (mammograms, brain MRIs, chest X-rays, and other modalities) to assist radiologists and healthcare institutions in faster, more accurate diagnosis. Its flagship consumer product, Entelai Doc, lets individuals obtain AI-assisted health assessments via WhatsApp, while its enterprise suite (Agent Mammo, Agent Neuro, Agent X-Ray, Agent Flex, Agent One) integrates into hospital RIS/PACS workflows across Latin America.
Is Entelai a public or private company?
Entelai is a private company. It is classified as venture growth investor backed and is currently operating.
When was Entelai founded?
Entelai was founded in 2019. It employs 11 to 50 people.
Where is Entelai based?
Entelai is headquartered in Buenos Aires, Argentina, in the Latin America region.
How does Entelai make money?
Four revenue lines are on record. AI Diagnostic Agents (Agent Mammo, Neuro, X-Ray) is the primary driver. The others are agent Flex - Enterprise Automation, agent One - Multimodal Diagnostic Platform and entelai Doc - Patient Services.
Does Entelai have an API?
No public API is recorded for Entelai.